Medication Safety Webinar: Important New Resources and Protocols

Thursday, February 23 | 10:00 AM - 11:00 AM WEBINAR

Register Now!

The Gillese Inquiry set clear recommendations for important measures all long-term care homes should take to enhance medication safety. Learn about new resources under development by the non-profit Institute for Safe Medication Practices (ISMP) Canada that respond to those recommendations. Ensure your home stays “in the know” about leading protocols and helpful tools that can help you to evaluate, benchmark and improve your safety program. Join us!

  • Hear details of ISMP Canada’s planned update of its Medication Safety Self-Assessment for Long-Term Care (MSSA-LTC), to reflect the Inquiry’s recommendations and include pro-active evaluation for potential and preventable “never events,” in which a resident suffers serious harm or death.
  • Find out about a separate, three-year joint project ISMP Canada is undertaking with Ontario’s Ministry of Health and Long-Term Care to further address the Gillese Inquiry’s recommendations around strengthening medication safety in LTC.
  • Get information about an opportunity to validate the updated MSSA-LTC tool.


Explore this session's speaker below!


Julie Greenall, RPh, Senior Director, Projects and Consultations, ISMP Canada

 
This initiative is supported by the Ministry of Long-Term Care.

Privacy Statement: Registration information is collected to process registrations and payments for education events, correspond with registered delegates, notify participants about other AdvantAge Ontario programs and services and to publish delegate lists for event participants. If you do not wish to have your registration information used for these purposes, please contact Olivia Rotundo at orotundo@advantageontario.ca. To access our privacy policy, click here.


Julie has more than 35 years of clinical and management experience in pharmacy practice in community hospitals, long-term care and community pharmacy. Julie joined ISMP Canada in 2004 to complete the first Canadian Fellowship in Safe Medication Management and became a staff member in 2005. In her current position, she is responsible for ISMP Canada’s consultation program. Julie has participated in numerous medication system reviews, root cause analyses of critical medication incidents and proactive risk assessment projects. Associated with these reviews, Julie has been an expert witness for coroner inquests. Julie provided testimony to the Ontario Long-Term Care Inquiry in 2018.